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Pre–Drug-Eluting Stent
Debulking of Bifurcated Coronary Lesions
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Objectives The purpose of this study was to evaluate the efficacy of plaque debulking by directional coronary atherectomy
(DCA) before drug-eluting stent (DES) implantation for bifurcated coronary lesions.
Background The introduction of DES significantly reduces restenosis and repeated revascularization. However, percutaneous
coronary intervention of bifurcated lesions using DES alone remains challenging regardless of whether simple or
complex stenting is used.
Methods Patients with bifurcated lesions were recruited in this prospective multicenter registry. Pre-DES plaque debulking
by DCA was conducted. All patients were scheduled to undergo a 9-month coronary angiography. The primary
end point was the 9-month binary angiographic restenosis rate. Secondary end points included procedure-related
events and major adverse cardiac events (MACE) at 1 year.
Results A total of 99 patients with bifurcated lesions were enrolled in this registry. Directional coronary atherectomy was
performed successfully in all cases without any major procedure-related events. Simple stenting was achieved in
all but 2 cases. No in-hospital MACE were observed. The 9-month binary restenosis rates in the main branch and
side branch were 1.1% and 3.4%, respectively. Target lesion revascularization was performed in 2 patients (1 for
the main branch and the other for the side branch). No deaths, no coronary artery bypass grafting, and no myo-
cardial infarctions were reported in the patients within the first year.
Conclusions Directional coronary atherectomy before DES implantation can possibly avoid complex stenting. This strategy
may provide a good long-term outcome in patients with bifurcated lesions. (J Am Coll Cardiol 2007;50:
1941–5) © 2007 by the American College of Cardiology Foundation
ublished by Elsevier Inc. doi:10.1016/j.jacc.2007.07.066c
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tercutaneous coronary intervention (PCI) of bifurcated
esions involving both the main and side branches remains
omplex and challenging in terms of technical demands and
as a higher risk of restenosis regardless of the stenting
trategy used (1). There are mainly 2 stenting strategies in
ifurcated lesions: 1) stenting the main branch with balloon
ngioplasty of the side branch (simple stenting); and 2)
tenting of both the main and the side branch (complex
tenting) (2). Previous studies comparing simple versus
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ccepted July 23, 2007.omplex stenting demonstrated comparable results between
he 2 strategies (3–5). However, in clinical practice, a
umber of bifurcated lesions will ultimately require complex
tenting (5), for example, if the side branch is of adequate
ize and heavily diseased with an atherosclerotic lesion
xtending from the main lesion into the proximal portion of
he branch. Unfortunately, reported restenosis rates (range
See page 1946
etween 9.1% and 18.8% in the main branch and between
1.1% and 25.3% in the side branch) in complex stenting
ere unsatisfactory regardless of the implantation of the
rug-eluting stent (DES) (6–8). The bifurcated lesion is
herefore still considered one of the remaining problems in
he DES era. To improve the treatment outcome, we used
irectional coronary atherectomy (DCA) mainly on the
ain branch before DES implantation for bifurcated lesions
o avoid a significant lumen reduction on the side branch,
hich requires complex stenting.
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Study design. The PERFECT
(PrE Rapamycin-eluting stent
FlExi-CuT) registry, conducted at
17 Japanese centers, was a multi-
center, prospective, nonrandom-
ized study to evaluate the efficacy
of pre-DES plaque modification
by DCA for bifurcated coronary
lesions. Suitable lesions for the
PERFECT registry were selected
by angiography, by intravascular
ultrasound (IVUS), and by the
clinical condition of the patient.
Inclusion criteria included signifi-
cant stenosis located in a distal left
main trunk, ostium of the left an-
terior descending or left circumflex
artery, or a major bifurcation lo-
cated at the proximal left anterior
descending or left circumflex; de
ovo lesion; suitable morphology for DCA catheter delivery
no severe calcification and acute proximal bending); and
eference diameter in main branch 2.5 mm by visual esti-
ate. Exclusion criteria included a bypass graft, bending60°,
estenotic lesion, thrombotic lesion, and acute myocardial
nfarction (within 2 weeks). Eligible patients were enrolled in
his registry. The protocol was approved by ethics committees
n each participating center, and all participants gave written
nformed consent.
rocedure and medication. Percutaneous coronary inter-
ention was performed through the femoral artery using an
-F sheath introducer. All patients underwent the IVUS-
uided DCA procedure in the main branch and in the side
ranch (when it was applicable) using a Flexicut (Abbott
ascular, Temecula, California) before implantation of a
irolimus-eluting stent (Cypher, Cordis Corp., Miami
akes, Florida). The IVUS-guided DCA was performed
ccording to a previous study (9). Balloon pressures were
ncreased progressively from 10 to 30 psi to a maximum of
50 psi. Repeated debulking of the plaque using IVUS was
erformed according to the residual percent plaque plus the
edia cross-sectional area (PA). The target residual percent
A was 60%. The DES was implanted after plaque
ebulking. The patients then underwent either single-
rossover stenting or single noncrossover stenting (Fig. 1).
ingle-crossover stenting is a technique in which the
ypher stent is placed in the main branch covering the side
ranch. It was followed by: 1) kissing balloon technique
KBT); or 2) balloon angioplasty only for the side branch
hen necessary. In single noncrossover stenting, optimal
ebulking is performed in the ostial of the main branch. The
ypher stent is then placed just distal to the main branch
stium without covering the side branch. All patients were
Abbreviations
and Acronyms
CK  creatine kinase
DCA  directional coronary
atherectomy
DES  drug-eluting stent(s)
IVUS  intravascular
ultrasound
KBT  kissing balloon
technique
MACE  major adverse
cardiac events
PA  plaque plus the
media cross-sectional area
PCI  percutaneous
coronary intervention
QMI  Q-wave myocardial
infarction
TLR  target lesion
revascularizationre-treated with aspirin and ticlopidine. A 200-mg loading kose of ticlopidine before the index procedure was admin-
stered in patients who were not pre-treated. Ticlopidine
ombined with aspirin was continued after stenting. Ad-
inistration of dual antiplatelet therapy was continued for 1
ear.
uantitative coronary angiography and IVUS. All an-
iographic and IVUS imaging was conducted immediately
fter administration of 200 g of intracoronary nitroglyc-
rin. Angiography was performed so that each lesion was
iewed from at least 2 angles. Quantitative coronary angiog-
aphy and IVUS were independently analyzed by a core
aboratory (Cardiovascular Imaging Center, Toyohashi,
apan). Quantitative coronary angiography analysis was
onducted using the Cardiovascular Measurement System
CMS-MEDIS, Medical Imaging Systems, Leiden, the
etherlands). Lesion length, reference diameter, minimal
umen diameter, and diameter stenosis were calculated. The
nalysis was performed in both the main and the side branch
efore and after procedures and at a 9-month follow-up.
he IVUS was performed using a commercially available
ystem (Boston Scientific, Natick, Massachusetts). The
otal vessel cross-sectional area and lumen cross-sectional
rea were calculated, and the difference between these 2
alues was defined as the PA. The PA was then divided by
he vessel cross-sectional area to obtain the percent PA.
atient follow-up. In-hospital assessment was performed
or all clinical outcomes, including hemorrhagic and vascu-
ar complications and routine ascertainment of creatine
Figure 1 Stenting Strategies
(A) Crossover stenting. The stent is placed in the main branch (MB) covering
the side branch (SB) after directional coronary atherectomy (DCA) debulking. It
was followed by kissing balloon technique (KBT) or balloon angioplasty (BA) for
the SB when necessary. (B) Noncrossover stenting. Plaque debulking by DCA
is performed in the MB. The stent is then placed in the MB ostium without cov-
ering the SB.inase (CK) and the CK-MB fraction before treatment and
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November 13, 2007:1941–5 Pre-DES Debulking of Bifurcationto 6 h and 24 h after procedure. After patient discharge,
linical follow-up examinations were conducted on an
utpatient basis at least once per month for 1 year. Angio-
raphic and IVUS follow-up examinations were conducted
t 9 months regardless of symptoms. If target lesion revas-
ularization (TLR) was performed before 9 months owing
o the clinical condition of the patient, before-procedural
ngiography at that time was used for follow-up quantitative
oronary angiography analysis of the patient.
nd points. The primary angiographic end point was the
-month binary angiographic restenosis rate, defined as
50% diameter stenosis. Secondary end points were
rocedure-related events and major adverse cardiac events
MACE) at 1 year. Procedure-related events included DCA
rocedural events (spasm, side branch occlusion, no flow,
erforation) and in-hospital MACE (death, emergency
oronary arterial bypass grafting/TLR, Q-wave myocardial
nfarction [QMI], complication at access site). All deaths
ere considered cardiac-related unless clearly attributable to
noncardiac cause. Documentation of new, pathological Q
aves in 2 or more contiguous electrocardiogram leads
ssociated with elevation of CK-MB was required for the
iagnosis of QMI. Non–QMI was defined as the elevation
f CK to more than twice the upper limit associated with
ny elevation of CK-MB without the appearance of Q
aves.
tatistical analysis. Each participating center was prospec-
ively required to record all patients’ data on case report
orms. Data were forwarded to the core laboratory for data
ntry and analysis. Data that were missing, inconsistent, or
oth were obtained or clarified by direct communication by
he core laboratory with the respective clinical center.
ontinuous variables were expressed as the mean  SD.
ariable categories were expressed as frequencies.
esults
atient and lesion characteristics. Between August 2004
nd October 2005, we screened 2,175 elective PCI patients.
f these, we enrolled 99 patients (99 lesions) who met the
nclusion criteria of the registry. Baseline patient demo-
raphic and clinical data are shown in Table 1. Baseline
aseline Patient Demographics
Table 1 Baseline Patient Demographics
n 99
Men 85 (86)
Age, yrs 67 11
Prior MI 37 (37)
Prior CABG 3 (3)
UA 25 (25)
HT 56 (57)
DM 25 (25)
HL 47 (47)
History of smoking 38 (38)
alues are presented as n (%) or mean  SD.(
CABG  coronary artery bypass surgery; DM  diabetes mellitus; HL  hyperlipidemia; HT 
ypertension; MI  myocardial infarction; UA  unstable angina.esion characteristics including Duke’s classification of bi-
urcated lesions (10) are summarized in Table 2. Sixty-three
esions (64%) were located in the left main trunk bifurca-
ion, 15 were located in the ostial left anterior descending
rtery, and 3 were in the ostial left circumflex. Thus, 81
esions (82%) were located around the left main trunk
ifurcation.
cute results. The DCA was performed using a FlexiCut
ize L in 98 lesions and a FlexiCut size M in 1 lesion.
laque excision of the main branch was conducted in all
esions. In 3 lesions (3%) involving the left main trunk
ifurcation, DCA was also performed for the ostial left
ircumflex artery (side branch). The total number of cuts was
8.2 12.3, with a maximum cutting pressure of 59.4 34.5
si. No complications (spasm, side branch occlusion, no
ow, or perforation) were observed during the plaque
ebulking. Successful stent delivery was achieved in all
ases. Simple stenting was performed in 97 cases (crossover
tent with KBT in 50, without any additional treatment in
6, with balloon angioplasty for side branch only in 6, and
oncrossover stent in 15). Only 2 cases with left main trunk
ifurcation (2%) required complex stenting (1 T-stent and 1
ulotte stent) because of unsatisfactory results after stenting
f the main branch. The mean stent size was 3.32  0.26
m, and the stent length was 21.9  4.2 mm. Quantitative
oronary angiography analysis for the main branch and side
ranch is shown in Table 3, and IVUS analysis of the main
ranch is shown in Table 4. After-DCA percent PA was
5.8  14.3%, which means that DCA debulking in this
tudy was not so aggressive.
The mean procedure time was 114.6  42.1 min (41.1 
6.4 min mean fluoroscopy time). The average use of
ontrast medium was 338  104 ml. During the procedure,
ntra-aortic balloon pumping was required in 11 patients
esion Demographics
Table 2 Lesion Demographics
Duke classification (n  99)
Type A 8 (8)
Type B 31 (31)
Type C 22 (22)
Type D 33 (33)
Type E 0 (0)
Type F 5 (5)
ACC/AHA classification (n  99)
A/B1 18 (18)
B2/C 81 (82)
Lesion location (n  99)
LMT bifurcation 63 (64)
LAD ostial 15 (15)
LCx ostial 3 (3)
LAD/diagonal 16 (16)
LCx/obtuse marginal 2 (2)
alues are presented as n (%).
ACC  American College of Cardiology; AHA  American Heart Association; LAD  left anterior
escending; LCx  left circumflex; LMT  left main trunk.11%). Of those, elective intra-aortic balloon pumping was
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Pre-DES Debulking of Bifurcation November 13, 2007:1941–5equired in 8 patients. No patient had any major complica-
ions (death, emergent coronary arterial bypass grafting/
LR, or QMI) from the procedure throughout the hospital
tay. Non–QMI occurred in 2 patients (2%). No hemor-
hagic vascular complications and no induced renal dysfunc-
ion were observed.
ollow-up results. Angiographic follow-up was performed
n 89 patients (90% follow-up rate) at a mean follow-up
eriod of 259  79 days. Follow-up quantitative coronary
ngiography results are shown in Table 3. Restenosis rates
f the main and side branch were 1.1% (1 of 89) and 3.4%
3 of 89) respectively, and the total restenosis rate, the
rimary end point of this study, was 4.5% (4 of 89).
ne-year clinical follow-up was accomplished in 96 patients
97% of the entire cohort). No deaths, coronary arterial
ypass grafting, or myocardial infarctions were reported in
hose patients. No stent thrombosis was observed. However,
LR was required in 1 patient in the main branch (1.0%)
nd in 1 patient in the side branch (1.0%). The former
atient, who had a left anterior descending/diagonal bifur-
ation lesion, initially underwent single-crossover stenting
ithout KBT after DCA of the left anterior descending. At
ngiographic follow-up, a focal restenosis was observed at
he proximal edge of the DES, which was easily retreated by
CA alone. The latter patient, who had an ostial stenosis in
he left anterior descending artery, underwent single-
rossover stenting with KBT. Restenosis occurred in the
stium of the left circumflex artery, and an additional DES
mplantation was successfully performed. Two other rest-
notic lesions were observed in the ostium of the diagonal
ranch, but neither required TLR due to lack of evidence of
schemia.
ubanalysis of left main trunk bifurcation. This subgroup
ncluded 63 patients (53 men) with a mean age of 69  11
CA Analysis of the Main and Side Branch
Table 3 QCA Analysis of the Main and Side Branch
Main Branch Side Branch
Before (n  99)
Lesion length (mm) 16.0 8.4 7.1 6.9
RVD (mm) 3.28 0.47 2.60 0.74
MLD (mm) 1.33 0.37 1.71 0.67
DS (%) 59.6 9.4 34.5 16.6
After (n  99)
RVD (mm) 3.76 0.46 2.73 0.72
MLD (mm) 3.43 0.65 2.14 0.64
DS (%) 9.1 11.6 21.4 14.6
Acute gain (mm) 2.09 0.63 0.32 0.56
Follow-up (n  89)
RVD (mm) 3.36 0.44 2.49 0.58
MLD (mm) 2.90 0.65 1.94 0.58
DS (%) 13.8 13.7 21.7 15.7
Late loss (mm) 0.52 0.53 0.15 0.44
Loss index 0.24 0.25 0.10 9.36
alues are presented as n (%) or mean  SD.
DS  diameter stenosis; MLD  minimum lumen diameter; QCA  quantitative coronary
ngiography; RVD  reference vessel diameter.ears. Successful DCA and DES implantation (60 simple, 2 uomplex) was completed without any MACE. Angio-
raphic follow-up was obtained in 55 patients, and the
estenosis rate was 0% for both the main and the side
ranch. Clinical follow-up at 1 year was completed in 60
atients, and no clinical event, including TLR, was observed
n any patient.
iscussion
rug-eluting stents significantly reduced restenosis rates
ompared with bare-metal stents in simple lesions. How-
ver, the issue of restenosis in complex anatomies such as
ifurcated coronary lesions remained unclear. Directional
oronary atherectomy was developed as a way of excising
oronary atheroma, possibly preventing plaque shift in
ifurcated lesions. In the PERFECT registry, we can make
he following conclusion: DCA before DES may lower the
estenosis rate without increasing adverse events.
dvantage of plaque debulking for bifurcated lesions. Pre-
ious studies compared the effectiveness of simple versus
omplex stenting in bifurcated lesions (3–5). The results of
hese studies indicated no significant differences between
he 2 groups with regard to the primary end points defined
n each study. Both strategies are effective in reducing the
estenosis rate compared with bare-metal stent implanta-
ion; therefore, simple stenting is a favorable treatment
trategy for stenting in bifurcated lesions. None of the
revious studies showed that stenting in the side branch
ecreased the restenosis rate. However, complex stenting is
ften inevitable, especially in the case of a true bifurcated
esion with a massive plaque burden. In a study comparing
omplex stenting with a simple stenting technique (stent in
he parent vessel plus balloon angioplasty of the side branch)
onducted by Assali et al. (5), 9 of 25 patients (36%) in the
imple stenting group underwent side branch “provisional”
tenting because of unsatisfactory results. Colombo et al.
11) reported a high crossover rate (51.2%) in a randomized
tudy to evaluate sirolimus-eluting stents implanted in
oronary bifurcation lesions. A high crossover rate may be
aused by plaque shift after the main branch stenting. A
VUS Analysis of the Main Branch
Table 4 IVUS Analysis of the Main Branch
Pre-DCA (n  99)
Lumen CSA (mm2) 2.46 1.17
Vessel CSA (mm2) 14.85 4.20
PA (%) 82.3 7.2
Post-DCA (n  99)
Lumen CSA (mm2) 6.50 2.33
Vessel CSA (mm2) 15.56 3.47
PA (%) 55.8 14.3
Final (n  99)
Lumen CSA (mm2) 9.31 3.28
Vessel CSA (mm2) 17.99 4.69
PA (%) 46.3 8.0
alues are presented as n (%) or mean  SD.
CSA  cross-sectional area; DCA  directional coronary atherectomy; IVUS  intravascular
ltrasound; PA  plaque area.
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November 13, 2007:1941–5 Pre-DES Debulking of Bifurcationrevious study investigating the clinical and angiographic
esults of DCA followed by stent implantation versus a
eries of matched lesions treated with stent implantation
lone for ostial left anterior descending artery showed that a
ignificant reduction in ostial left circumflex artery occurred
n patients treated with stenting alone, whereas DCA stent
xpansion was effective in avoiding a significant lumen
eduction in the left circumflex artery (12). Thus, plaque
hift and complex stenting can be minimized by the use of
CA debulking. In our registry, only 2 patients (2%)
nderwent provisional stenting in the side branch, which
ay have contributed to the low restenosis rate. Thus,
laque debulking before DES implantation in bifurcated
esions possibly offers an optimal treatment outcome, espe-
ially in bifurcated lesions that are expected to require stent
mplantation in the side branch. PCI of left main trunk
ifurcation lesions, even with a DES, remains challenging
11). Compared with nondistal left main trunk lesions, a
revious study showed a high in-stent restenosis rate of 13%
13). In the PERFECT registry, a 0% restenosis rate of left
ain trunk bifurcated lesions was achieved by the use of
CA debulking before DES implantation. Despite the lack
f strong scientific evidence supporting the advantage of
laque debulking in bifurcated lesions, these results strongly
uggest that it is preferable to combine DCA and DES
hen the anatomical setting is appropriate to achieve a good
ong-term outcome.
tudy limitations. The main limitation is the characteris-
ics of the lesions involved in the PERFECT registry, which
ncluded lesions with a larger reference vessel diameter and
ithout severe calcification that are suitable for DCA. In
ddition, DCA involves specific procedural techniques such
s the precise evaluation of plaque distribution by IVUS
nd the appropriate control of athero-catheters. Thus,
onger procedural and fluoroscopy times are required, as
ell as in-depth training of operators. Furthermore, the
tudy was performed in a nonrandomized manner. Al-
hough this was a multicenter registry, only 99 patients
ere included. Therefore, a prospective randomized trial
s required to demonstrate the efficacy of pre-DES
ebulking by DCA for bifurcated lesions.
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